Literature DB >> 28887654

[Critical consideration of ipsilateral axillary recurrence after breast conservative surgery and the protective effect of whole breast radiotherapy].

Frederik Wenz1, Elena Sperk2.   

Abstract

Mesh：

Year:  2017        PMID： 28887654     DOI： 10.1007/s00066-017-1202-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  15 in total

1.  Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

Authors:  Ian H Kunkler; Linda J Williams; Wilma J L Jack; David A Cameron; J Michael Dixon
Journal:  Lancet Oncol       Date:  2015-01-28       Impact factor: 41.316

2.  Regional Nodal Irradiation in Early-Stage Breast Cancer.

Authors:  Timothy J Whelan; Ivo A Olivotto; Wendy R Parulekar; Ida Ackerman; Boon H Chua; Abdenour Nabid; Katherine A Vallis; Julia R White; Pierre Rousseau; Andre Fortin; Lori J Pierce; Lee Manchul; Susan Chafe; Maureen C Nolan; Peter Craighead; Julie Bowen; David R McCready; Kathleen I Pritchard; Karen Gelmon; Yvonne Murray; Judy-Anne W Chapman; Bingshu E Chen; Mark N Levine
Journal:  N Engl J Med       Date:  2015-07-23       Impact factor: 91.245

3.  Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.

Authors:  Philip M Poortmans; Sandra Collette; Carine Kirkove; Erik Van Limbergen; Volker Budach; Henk Struikmans; Laurence Collette; Alain Fourquet; Philippe Maingon; Mariacarla Valli; Karin De Winter; Simone Marnitz; Isabelle Barillot; Luciano Scandolaro; Ernest Vonk; Carla Rodenhuis; Hugo Marsiglia; Nicola Weidner; Geertjan van Tienhoven; Christoph Glanzmann; Abraham Kuten; Rodrigo Arriagada; Harry Bartelink; Walter Van den Bogaert
Journal:  N Engl J Med       Date:  2015-07-23       Impact factor: 91.245

4.  Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial.

Authors:  Lorenzo Livi; Icro Meattini; Livia Marrazzo; Gabriele Simontacchi; Stefania Pallotta; Calogero Saieva; Fabiola Paiar; Vieri Scotti; Carla De Luca Cardillo; Paolo Bastiani; Lorenzo Orzalesi; Donato Casella; Luis Sanchez; Jacopo Nori; Massimiliano Fambrini; Simonetta Bianchi
Journal:  Eur J Cancer       Date:  2015-01-17       Impact factor: 9.162

5.  Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial.

Authors:  R W Blamey; T Bates; U Chetty; S W Duffy; I O Ellis; D George; E Mallon; M J Mitchell; I Monypenny; D A L Morgan; R D Macmillan; J Patnick; S E Pinder
Journal:  Eur J Cancer       Date:  2013-03-21       Impact factor: 9.162

6.  Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.

Authors:  Richard Pötter; Michael Gnant; Werner Kwasny; Christoph Tausch; Leonore Handl-Zeller; Brigitte Pakisch; Susanne Taucher; Josef Hammer; Gero Luschin-Ebengreuth; Marianne Schmid; Felix Sedlmayer; Michael Stierer; Georg Reiner; Karin Kapp; Friedrich Hofbauer; Andrea Rottenfusser; Sabine Pöstlberger; Karin Haider; Wolfgang Draxler; Raimund Jakesz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-23       Impact factor: 7.038

7.  Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.

Authors:  Umberto Veronesi; Roberto Orecchia; Patrick Maisonneuve; Giuseppe Viale; Nicole Rotmensz; Claudia Sangalli; Alberto Luini; Paolo Veronesi; Viviana Galimberti; Stefano Zurrida; Maria Cristina Leonardi; Roberta Lazzari; Federica Cattani; Oreste Gentilini; Mattia Intra; Pietro Caldarella; Bettina Ballardini
Journal:  Lancet Oncol       Date:  2013-11-11       Impact factor: 41.316

8.  5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.

Authors:  Vratislav Strnad; Oliver J Ott; Guido Hildebrandt; Daniela Kauer-Dorner; Hellen Knauerhase; Tibor Major; Jaroslaw Lyczek; Jose Luis Guinot; Jürgen Dunst; Cristina Gutierrez Miguelez; Pavel Slampa; Michael Allgäuer; Kristina Lössl; Bülent Polat; György Kovács; Arnt-René Fischedick; Thomas G Wendt; Rainer Fietkau; Marion Hindemith; Alexandra Resch; Anna Kulik; Leo Arribas; Peter Niehoff; Fernando Guedea; Annika Schlamann; Richard Pötter; Christine Gall; Martina Malzer; Wolfgang Uter; Csaba Polgár
Journal:  Lancet       Date:  2015-10-19       Impact factor: 79.321

9.  Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Authors:  Charlotte E Coles; Clare L Griffin; Anna M Kirby; Jenny Titley; Rajiv K Agrawal; Abdulla Alhasso; Indrani S Bhattacharya; Adrian M Brunt; Laura Ciurlionis; Charlie Chan; Ellen M Donovan; Marie A Emson; Adrian N Harnett; Joanne S Haviland; Penelope Hopwood; Monica L Jefford; Ronald Kaggwa; Elinor J Sawyer; Isabel Syndikus; Yat M Tsang; Duncan A Wheatley; Maggie Wilcox; John R Yarnold; Judith M Bliss
Journal:  Lancet       Date:  2017-08-02       Impact factor: 79.321

10.  Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

Authors:  Jayant S Vaidya; Frederik Wenz; Max Bulsara; Jeffrey S Tobias; David J Joseph; Mohammed Keshtgar; Henrik L Flyger; Samuele Massarut; Michael Alvarado; Christobel Saunders; Wolfgang Eiermann; Marinos Metaxas; Elena Sperk; Marc Sütterlin; Douglas Brown; Laura Esserman; Mario Roncadin; Alastair Thompson; John A Dewar; Helle M R Holtveg; Steffi Pigorsch; Mary Falzon; Eleanor Harris; April Matthews; Chris Brew-Graves; Ingrid Potyka; Tammy Corica; Norman R Williams; Michael Baum
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.